Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-04-25 @ 4:43 PM
Study NCT ID:
NCT01614002
Status:
COMPLETED
Last Update Posted:
2015-06-04
First Post:
2012-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer
Sponsor:
Onkovis GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | carcinoma | View |
| None | breast cancer | View |
| None | non-small cell lung cancer | View |
| None | prostata cancer | View |
| None | adenocarcinoma of the stomach | View |
| None | squamous cell carcinoma of the head and neck region | View |
| None | ambulant chemotherapy | View |
| None | treatment cycles | View |
| None | Docetaxel | View |
| None | Doce onkovis | View |
| None | Quantity of Docetaxel | View |
| None | Packaging Sizes | View |